feeding tube Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 2 (1)

Interventional (1)

Nader Sadeghi (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadneutrophil count

I am/have/hadsquamous cell carcinoma

I am/have/hadcarcinoma

I am/have/hadcancer

I am/have/hadkarnofsky performance status

I am/have/hadpapilloma

I am/have/haddefinitive treatment

I am/have/hadabsolute neutrophil count

I am/have/hadmetastasis

I am/have/hadneck dissection

I am/have/hadchemo-radiotherapy

I am/have/hadhuman papillomavirus

I am/have/hadoropharyngeal

I am/have/hadoropharyngeal cancer

I am/have/hadprimary tumor

I am/have/hadrobotic surgery

added new label for I am/have/had

more

I am looking for

I am looking fordocetaxel

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Cancer.

The objective of this trial is to study the efficacy of treatment of human papilloma virus (HPV) related oropharyngeal cancer with chemotherapy followed by Transoral Robotic Surgery (TORS) as definitive treatment. Current treatment of oropharyngeal cancer are chemo-radiotherapy. There is significant lifelong side effects associated with this approach related to …

neutrophil count

squamous cell carcinoma

cancer

carcinoma

karnofsky performance status

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.